This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université Laval directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Bazedoxifene and Beyond: Identifying This SERM's Targets and Deciphering Its Molecular Mechanisms.
Advances in pharmacological and pharmaceutical sciences · 2026 · senior author
Mammary Adipocyte Size, Obesity-Related Breast Adipose Tissue Dysfunction, and Breast Cancer: A Systematic Review and Meta-Analysis.
Cancers · 2026
Aminosteroid RM-581 Induces G0/G1 Arrest and Endoplasmic Reticulum Stress-Mediated Apoptosis in Human Acute and Chronic Leukemia Cell Lines.
Cancers · 2026
Latest funding
- $1,262,250
Développement translationnel de l'AIMZ-938 comme thérapie de précision pour les cancers colorectaux réfractaires aux traitements
CIHR · 2026 · Principal investigator
- $642,600
Mise au point d'inhibiteurs covalents sélectifs pour le traitement et le diagnostic de cancers qui expriment la 17beta-HSD1
CIHR · 2025 · Co-investigator
- $120,000
Bazédoxifène, médicament contre l'ostéoporose, pour le traitement et la prévention du cancer du sein ?
CIHR · 2024 · Supervisor
58 publications.
Bazedoxifene and Beyond: Identifying This SERM's Targets and Deciphering Its Molecular Mechanisms.
Bherer J, Clemenceau A, Diorio C, Durocher F
Mammary Adipocyte Size, Obesity-Related Breast Adipose Tissue Dysfunction, and Breast Cancer: A Systematic Review and Meta-Analysis.
Badre O, Chang SL, Abdous B, Lemieux J, Durocher F, Tchernof A, Diorio C
Aminosteroid RM-581 Induces G0/G1 Arrest and Endoplasmic Reticulum Stress-Mediated Apoptosis in Human Acute and Chronic Leukemia Cell Lines.
Fleury M, Roy J, Maltais R, Durocher F, Poirier D
Clinical and prognostic significance of parathyroid hormone-related protein in breast cancer: a systematic review and meta-analyses of observational studies in women.
Clemenceau A, Bherer J, Grimshaw A, Durocher F, Diorio C, Wysolmerski JJ
FOXA1 and RAB25 as Biomarkers of Breast Cancer Cell Response to CYP1A1-Activated Prodrugs: Insights from CEU-938.
Bruxelles Q, Hamel-Côté G, Scott-Boyer MP, Ouellette V, C-Gaudreault R, Durocher F, Diorio C, Droit A, Fortin S
Factors influencing traditional adiposity indicators and mammary adipocyte size in women with breast cancer.
Ennour-Idrissi K, Laforest S, Tchernof A, Durocher F, Diorio C
Aminosteroid RM-581 Decreases Cell Proliferation of All Breast Cancer Molecular Subtypes, Alone and in Combination with Breast Cancer Treatments.
Burguin A, Roy J, Ouellette G, Maltais R, Bherer J, Diorio C, Poirier D, Durocher F
Role of Secreted Frizzled-Related Protein 1 in Early Breast Carcinogenesis and Breast Cancer Aggressiveness.
Clemenceau A, Lacouture A, Bherer J, Ouellette G, Michaud A, Audet-Walsh É, Diorio C, Durocher F
Sleep quality traits correlate with inflammatory markers in the breast tissue of women.
Chang SL, Durocher F, Diorio C
Exploring the impact of night shift work on methylation of circadian genes.
Ritonja JA, Aronson KJ, Flaten L, Topouza DG, Duan QL, Durocher F, Tranmer JE, Bhatti P
Développement translationnel de l'AIMZ-938 comme thérapie de précision pour les cancers colorectaux réfractaires aux traitements
Principal investigators: Fortin, Sébastien; Benoit-Biancamano, Marie-Odile; C.-Gaudreault, René; Diorio, Caroline; Droit, Arnaud; Durocher, Francine; Moreau, Emmanuel; Simard, Chantale
Keywords: Antimitotiques; Cancers Colorectaux; Cancers Colorectaux Métastatiques Et Chimiorésistants; Chimiothérapie Personnalisée; Développement De Médicaments Anticancéreux; Modulateurs D'Ahr; Promédicaments Antimicrotubules
Mise au point d'inhibiteurs covalents sélectifs pour le traitement et le diagnostic de cancers qui expriment la 17beta-HSD1
Principal investigators: Poirier, Donald
Keywords: 17beta-Hydroxystéroïde Déshydrogénase; Cancer De L'Endomètre; Cancer Du Sein; Diagnostic; Enzyme; Estrogène; Inhibiteur Covalent; Stéroïde; Synthèse Chimique; Traitement
Bazédoxifène, médicament contre l'ostéoporose, pour le traitement et la prévention du cancer du sein ?
Principal investigators: Bherer, Juliette
Keywords: Bazédoxifène; Cancer Du Sein; Interleukine 6; Récepteurs Aux Cannabinoïdes; Serm; Survie; Traitement; Triple-Négatif
TBC1D9: therapeutic target of the aggressiveness of triple negative breast cancer
Principal investigators: Durocher, Francine
Keywords: Biomarker; Breast Cancer; Tbc1 Domain Family Member 9; Tbc1d9; Therapeutic Target; Treatment Option; Triple Negative Breast Cancer
L'AIMZ-938, un nouveau promédicament anticancéreux pour le traitement des cancers du sein humain réfractaires aux traitements actuels et exprimant le cytochrome P450 1A1
Principal investigators: Fortin, Sébastien
Keywords: Antimitotiques; Cancers Du Sein; Cancers Du Sein Chimiorésistants; Cancers Du Sein Triple Négatifs; Chimiothérapie Personnalisée; Développement De Médicaments Anticancéreux; Promédicaments Antimicrotubules
Omega-3 fatty acids in the prevention of breast cancer: role of obesity-related markers in breast tissues
Principal investigators: Diorio, Caroline
Keywords: Adipose Tissue; Aromatase; Breast Cancer; Breast Density; Inflammation; Molecular Markers; Nutrition; Obesity; Omega-3 Fatty Acids; Prevention
Deciphering breast cancer HER2-negativity with regard to HER2-targeted therapy
Principal investigators: Durocher, Francine
Keywords: Breast Cancer Prevention; Breast Cancer Treatment; Breast Tumors; Gene Expression Profile; Her2 Biomarker; Her2 Protein Variants; Her2-Targeted Therapy; Methylation Profile
Effect of environmental contaminants and methylome of breast adipose tissue on aromatase inhibitor efficacy in breast cancer
Principal investigators: Diorio, Caroline
Keywords: Adipose Tissue; Aromatase Inhibitors; Breast Cancer; Environmental Contaminants; Estrogen; Mass Spectometry; Methylation; Treatment
Études fonctionnelle des variants d'épissage de FANCA et effets sur la réparation de l'ADN
Principal investigators: St-Laurent Pedneault, Christopher W
Keywords: Anémie De Fanconi; Cancer Du Sein; Cycle Cellulaire; Expression Génique; Hérédité; Localisation Cellulaire; Recherche De Mutations; Réparation De L'Adn; Tumorigénèse; Épissage Alternatif
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Molecular Medicine
- Social and Preventive Medicine
- Microbiologie et immunologie
- Médecine
- Pediatrics
- Other
Co-authors at Université Laval, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Caroline Diorio
Social and Preventive Medicine
33 shared papers, latest 2026
Jacques Simard
Faculty
11 shared papers, latest 2017
Parveen Bhatti
Faculty
3 shared papers, latest 2022
Jacques Corbeil
Molecular Medicine
2 shared papers, latest 2020
Donald Poirier
Molecular Medicine
2 shared papers, latest 2026
Arnaud Droit
Microbiologie et immunologie
2 shared papers, latest 2026
Sabine Elowe
Pediatrics
1 shared papers, latest 2022
Jean-Philippe Lambert
Molecular Medicine
1 shared papers, latest 2020
Dave Richard
Faculty
1 shared papers, latest 2019
Laetitia Michou
Médecine
1 shared papers, latest 2020
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.